Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Olfactory dysfunction in Alzheimer's disease.

Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY.

Neuropsychiatr Dis Treat. 2016 Apr 15;12:869-75. doi: 10.2147/NDT.S104886. eCollection 2016. Review.

2.

Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ.

Acta Neuropathol. 2016 Mar;131(3):393-409. doi: 10.1007/s00401-015-1526-9. Epub 2015 Dec 31.

PMID:
26721587
3.

Odor identification and Alzheimer disease biomarkers in clinically normal elderly.

Growdon ME, Schultz AP, Dagley AS, Amariglio RE, Hedden T, Rentz DM, Johnson KA, Sperling RA, Albers MW, Marshall GA.

Neurology. 2015 May 26;84(21):2153-60. doi: 10.1212/WNL.0000000000001614. Epub 2015 May 1.

4.

Poorer Financial and Health Literacy Among Community-Dwelling Older Adults With Mild Cognitive Impairment.

Han SD, Boyle PA, James BD, Yu L, Bennett DA.

J Aging Health. 2015 Sep;27(6):1105-17. doi: 10.1177/0898264315577780. Epub 2015 Apr 22.

5.

Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation.

Yang MH, Lin LC, Wu SC, Chiu JH, Wang PN, Lin JG.

BMC Complement Altern Med. 2015 Mar 29;15:93. doi: 10.1186/s12906-015-0612-9.

6.

Olfactory dysfunction predicts 5-year mortality in older adults.

Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK.

PLoS One. 2014 Oct 1;9(10):e107541. doi: 10.1371/journal.pone.0107541. eCollection 2014.

7.

Computational genetics analysis of grey matter density in Alzheimer's disease.

Zieselman AL, Fisher JM, Hu T, Andrews PC, Greene CS, Shen L, Saykin AJ, Moore JH.

BioData Min. 2014 Aug 22;7:17. doi: 10.1186/1756-0381-7-17. eCollection 2014.

8.

At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI.

Alzheimers Dement. 2015 Jan;11(1):70-98. doi: 10.1016/j.jalz.2014.04.514. Epub 2014 Jul 9. Review.

9.

Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study.

Walla P, Duregger C, Deecke L, Dal-Bianco P.

Brain Sci. 2011 Oct 28;1(1):3-15. doi: 10.3390/brainsci1010003.

10.

Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.

Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, Liu R, Miller GW, Nussbaum R, Peddada SD, Rick AC, Ritz B, Siderowf AD, Tanner CM, Tröster AI, Zhang J.

Environ Health Perspect. 2013 Nov-Dec;121(11-12):1245-52. doi: 10.1289/ehp.1306967. Epub 2013 Aug 9. Review.

11.

Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.

Sachdev PS, Lipnicki DM, Crawford J, Reppermund S, Kochan NA, Trollor JN, Wen W, Draper B, Slavin MJ, Kang K, Lux O, Mather KA, Brodaty H; Sydney Memory, Ageing Study Team.

PLoS One. 2013;8(3):e59649. doi: 10.1371/journal.pone.0059649. Epub 2013 Mar 27.

12.

Olfactory assessment using the NIH Toolbox.

Dalton P, Doty RL, Murphy C, Frank R, Hoffman HJ, Maute C, Kallen MA, Slotkin J.

Neurology. 2013 Mar 12;80(11 Suppl 3):S32-6. doi: 10.1212/WNL.0b013e3182872eb4.

13.

Olfactory dysfunction: common in later life and early warning of neurodegenerative disease.

Hüttenbrink KB, Hummel T, Berg D, Gasser T, Hähner A.

Dtsch Arztebl Int. 2013 Jan;110(1-2):1-7, e1. doi: 10.3238/arztebl.2013.0001. Epub 2013 Jan 7. Review.

14.

Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults.

Seligman SC, Kamath V, Giovannetti T, Arnold SE, Moberg PJ.

Aging Ment Health. 2013;17(5):564-70. doi: 10.1080/13607863.2013.768208. Epub 2013 Feb 12.

15.

Somatostatinergic systems: an update on brain functions in normal and pathological aging.

Martel G, Dutar P, Epelbaum J, Viollet C.

Front Endocrinol (Lausanne). 2012 Dec 6;3:154. doi: 10.3389/fendo.2012.00154. eCollection 2012.

16.
17.

Olfactory discrimination predicts cognitive decline among community-dwelling older adults.

Sohrabi HR, Bates KA, Weinborn MG, Johnston AN, Bahramian A, Taddei K, Laws SM, Rodrigues M, Morici M, Howard M, Martins G, Mackay-Sim A, Gandy SE, Martins RN.

Transl Psychiatry. 2012 May 22;2:e118. doi: 10.1038/tp.2012.43.

18.

Smell and taste disorders.

Hummel T, Landis BN, Hüttenbrink KB.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc04. doi: 10.3205/cto000077. Epub 2012 Apr 26.

19.

Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?

Kisby G, Palmer V, Lasarev M, Fry R, Iordanov M, Magun E, Samson L, Spencer P.

Commun Integr Biol. 2011 Nov 1;4(6):731-4.

20.

Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer's disease.

Haase L, Wang M, Green E, Murphy C.

Hum Brain Mapp. 2013 Mar;34(3):530-42. doi: 10.1002/hbm.21451. Epub 2011 Nov 18.

Items per page

Supplemental Content

Write to the Help Desk